Association of depression screening with diagnostic and treatment-related outcomes among youth

Kira E. Riehm, Emily Brignone, Elizabeth A. Stuart, Joseph J. Gallo, Ramin MojtabaimedRxiv 2021 · DOI

Abstract

Background and Objectives: Universal depression screening is recommended in U.S. primary care to identify and connect adolescents to treatment. However, the longitudinal impact of screening on diagnosis and subsequent mental health care access remains under-explored. This study aimed to determine if screening leads to higher rates of diagnosis and treatment.

Methods: This longitudinal cohort study utilized insurance claims data from 57,732 adolescents (ages 12–18) who had routine well-visits between 2014 and 2017. Using propensity score matching (PSM), the researchers compared adolescents who were screened for depression to a matched cohort of unscreened peers. Outcomes included depression and mood-related diagnoses, antidepressant prescriptions, and psychotherapy over a 6-month follow-up period.

Results: Screened adolescents were 30% more likely to receive a depression diagnosis (RR=1.30, 95% CI=1.11-1.52) and 17% more likely to receive a mood-related diagnosis (RR=1.17, 95% CI=1.08-1.27). However, screening did not significantly increase the likelihood of receiving antidepressant prescriptions (RR=1.11) or psychotherapy (RR=1.13). Associations were generally stronger among female participants.

Conclusions: While screening successfully identifies youth with depression, it does not necessarily lead to increased treatment uptake. Future efforts must focus on bridging the gap between identification and care.

Introduction

Depression is a leading cause of disability among adolescents, with U.S. prevalence rates rising steadily over the last decade. In response, the U.S. Preventive Services Task Force (USPSTF) recommends universal screening for youth aged 12–18 in primary care settings. Despite these recommendations, a critical question remains: Does the act of screening actually improve clinical outcomes by connecting youth to necessary care?

Because universal screening is a standard clinical recommendation, conducting randomized controlled trials (RCTs) is ethically complex. This study addresses this evidence gap by using observational insurance data and advanced statistical matching to simulate the rigor of a controlled trial.

Methods

Study Design and Data Source

The researchers conducted a longitudinal cohort study using healthcare and pharmacy claims data from Highmark Health, a large non-profit insurer in the Eastern United States (Pennsylvania, West Virginia, and Delaware). The study period spanned from 2014 to 2017.

Participant Selection

The sample included 57,732 adolescents who met the following criteria:

  • Aged 12–18 at the time of a routine well-visit.
  • No history of depression or mental health treatment in the six months prior to the visit.

Statistical Analysis

To account for selection bias—the tendency for doctors to screen patients they already suspect are depressed—the team used Propensity Score Matching (PSM). Screened adolescents (n=14,433) were matched with unscreened peers (n=43,299) based on age, sex, race, rurality, prior healthcare usage, and provider specialty. Risk Ratios (RRs) were then calculated using log-binomial regression to compare outcomes over a six-month follow-up.

Key Results

The Identification Success

Screening proved to be an effective tool for clinical identification. Compared to the matched unscreened group, screened adolescents were:

  • 30% more likely to be diagnosed with depression (RR=1.30, 95% CI=1.11-1.52).
  • 17% more likely to receive a broader mood-related diagnosis (RR=1.17, 95% CI=1.08-1.27).

The Treatment Gap

Despite the increase in diagnoses, there was no statistically significant increase in treatment initiation for the overall cohort:

  • Antidepressant prescriptions: RR=1.11 (95% CI=0.82-1.51).
  • Psychotherapy: RR=1.13 (95% CI=0.98-1.31).

Gender Differences

When the data was stratified by sex, a notable difference emerged. Screened females were significantly more likely to receive psychotherapy (RR=1.22) following a screen, an effect not observed in males. This suggests that screening may be more effective at capturing internalizing symptoms common in females or that females face fewer stigmas when seeking follow-up care.

Discussion

The "Implementation Gap"

The findings highlight a "leaky pipeline" in adolescent mental health. While primary care providers are increasingly adopting screening guidelines—with rates in this study rising from 2% in 2014 to 13.6% in 2017—the transition from diagnosis to intervention remains a major hurdle. Identifying a teen in need is only the first step; structural barriers, provider shortages, and patient-level factors continue to impede access to care.

Limitations

As with all claims-based research, this study has limitations. Claims data indicates that a screen occurred but does not provide the result of that screen. Additionally, the data may not capture care provided outside of the insurance network, such as school-based counseling or services paid for out-of-pocket.

Conclusion and Future Directions

Universal depression screening is a vital diagnostic tool, but it is not a panacea. To improve adolescent outcomes, the focus must shift toward integrated care models. Strategies such as "warm hand-offs"—where a primary care doctor introduces the patient to a behavioral health specialist during the same visit—and collaborative care frameworks are essential to ensure that a positive screen leads to meaningful treatment.

Summary updated

Abstract

Abstract Background and Objectives The goals of depression screening, which is universally recommended in primary care settings in the U.S., are to identify adolescents with depression and connect them to treatment. However, little is known about how depression screening affects the likelihood of being diagnosed with a mental disorder or accessing mental health care over time. Methods This longitudinal cohort study used insurance claims data from 57,732 adolescents who had at least one routine well-visit between 2014 and 2017. Using propensity score matching, we compared adolescents who were screened for depression to similar adolescents who were not screened for depression during the well-visit. Diagnostic and treatment-related outcomes were examined over 6-month follow-up and included depression diagnoses, mood-related diagnoses, antidepressant prescriptions, any mental health-related prescriptions, and psychotherapy. We also examined heterogeneity of associations by sex. Results Compared to adolescents who were not screened for depression, adolescents screened for depression were 30% more likely to be diagnosed with depression (RR=1.30, 95% CI=1.11-1.52) and 17% more likely to receive a mood-related diagnosis (RR=1.17, 95% CI=1.08-1.27), but were not more likely to be treated with an antidepressant prescription (RR=1.11, 95% CI=0.82-1.51), any mental health prescription (RR=1.15, 95% CI=0.87-1.53), or psychotherapy (RR=1.13, 95% CI=0.98-1.31). In general, associations were stronger among females. Conclusions Adolescents who were screened for depression during a well-visit were more likely to receive a diagnosis of depression or a mood-related disorder in the six months following screening. Future research should explore methods for increasing access to treatment and treatment uptake following screening. Clinical Trial Registration (if any) N/A Table of Contents Summary Insurance claims data were used to explore associations between depression screening during routine well-visits and depression diagnoses, psychiatric prescriptions, and psychotherapy among adolescents. What’s Known on This Subject Depression screening is increasingly viewed as a key strategy for addressing depression among adolescents. To inform clinical guidelines, the United States Preventive Services Task Force has called for research to examine the diagnostic and treatment-related outcomes of depression screening. What This Study Adds In a sample of 57,732 adolescents, adolescents who were screened for depression during a well-visit were more likely to receive a depression or mood-related diagnosis over 6-month follow-up, but were not more likely to be treated with medication or psychotherapy.
BibTeX
@misc{riehm2021association,
  author = {Kira E. Riehm and Emily Brignone and Elizabeth A. Stuart and Joseph J. Gallo and Ramin Mojtabai},
  title = {{Association of depression screening with diagnostic and treatment-related outcomes among youth}},
  year = {2021},
  doi = {10.1101/2021.04.29.21256334},
  howpublished = {medRxiv},
}
Figure